Showing 8 articles tagged 'Genetics':
Our new precision medicine research programme aims to tailor treatments based on the genetic make-up of a man’s prostate cancer. The results could extend the lives of more than 9,000 men with advanced disease every year in the UK.
Deciding whether 'to treat or not to treat' localised prostate cancer is one of the biggest dilemmas for men and their doctors. Now new research from one of our Centres of Excellence could help identify which cancers are likely to spread and which are harmless.
We welcome today's reports of a new test by scientists at the University of East Anglia to determine whether a prostate cancer is aggressive or not, but the tell-tale pattern of 45 specific genes hasn't yet been proven to work for all men.
BLOG: We're only 12 months into our ten-year strategy to tame prostate cancer, but that doesn't mean we haven't already made exciting progress. Our resident expert, Dr Ian Le Guillou, gives us his top ten biggest research breakthroughs (in no particular order) from 2016.
Two research projects, using cutting-edge liquid biopsy technology to help improve diagnosis and treatment of men with prostate cancer, have been awarded funds by Prostate Cancer UK with the hope they'll used with real patients in the near future.
BLOG: With our new grants for research into the uses of liquid biopsies, Dr Sophie Lutter explains why they allow scientists to read clues about how a prostate cancer responds to treatment, and how they could revolutionise the way men are diagnosed and monitored with the disease.
Research published today has discovered a far higher proportion of inherited DNA mutations in men with advanced prostate cancer than previously suspected, opening up new possibilities for targeted treatments.
As new research emerges to confirm that over 11% of men with advanced prostate cancer have inherited mutations in genes that repair breaks in our DNA, we speak to Sarah Rose, a genetic counsellor at Guys and St Thomas’ NHS Trust, about the current availability of genetic testing for men with prostate cancer on the NHS and the difficult questions it raises.